49.03
+0.32(+0.66%)
Currency In USD
| Previous Close | 48.71 |
| Open | 48.95 |
| Day High | 49.25 |
| Day Low | 45.01 |
| 52-Week High | 56.83 |
| 52-Week Low | 10.14 |
| Volume | 832,140 |
| Average Volume | 498,916 |
| Market Cap | 635.91M |
| PE | -1.84 |
| EPS | -26.68 |
| Moving Average 50 Days | 25.48 |
| Moving Average 200 Days | 20.1 |
| Change | 0.32 |
If you invested $1000 in Cidara Therapeutics, Inc. (CDTX) 10 years ago, it would be worth $167.34 as of July 02, 2025 at a share price of $49.03. Whereas If you bought $1000 worth of Cidara Therapeutics, Inc. (CDTX) shares 5 years ago, it would be worth $667.98 as of July 02, 2025 at a share price of $49.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire Inc.
3 hours ago
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that the Compensation and
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
GlobeNewswire Inc.
Jun 30, 2025 12:00 PM GMT
SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its addition to the Russel
Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire Inc.
Jun 26, 2025 9:15 PM GMT
SAN DIEGO, June 26, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced the closing of its